氯己定沐浴预防血液科非重症病房中心静脉导管相关血流感染的前瞻性对照队列研究
该前瞻性对照队列研究纳入非重症病房接受细胞毒性化疗的血液恶性肿瘤成人患者,比较每日2%氯己定沐浴组(485例)与常规护理组(408例)。
核心结论
- 对于非重症病房接受细胞毒性化疗的血液恶性肿瘤患者,每日2%氯己定沐浴可高效预防革兰阳性球菌相关、皮肤菌群相关或中心静脉导管相关菌血症。
研究设计与样本
- 前瞻性对照队列研究,非重症病房接受细胞毒性化疗的血液恶性肿瘤成人患者,选择每日2%氯己定沐浴者485例为氯己定组,未选择者为常规护理组408例。
主要发现
- 氯己定组参与者对沐浴耐受良好。
临床怎么用
- 可考虑对非重症病房接受细胞毒性化疗的血液恶性肿瘤患者提供每日2%氯己定沐浴以预防特定类型血流感染。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chlorhexidine (CHG) bathing decreases the incidence of bloodstream infections in intensive care units, but its effect has been understudied in patients with hematological malignancies in noncritical care units. METHODS: Adults with hematological malignancies hospitalized for cytotoxic chemotherapy in noncritical care units were offered daily 2% CHG bathing. We compared outcomes of patients who chose CHG bathing (CHG group) with outcomes of those who did not choose CHG bathing (usual-care group). The primary outcome was gram-positive cocci-related, skin flora-related, or central line-associated bloodstream infection. The negative control outcome was gut-origin bacteremia. RESULTS: The CHG group (n = 485) had a crude incidence rate of the primary outcome that was 60% lower than the rate for the usual-care group (n = 408; 3.4 vs 8.4 per 1000 patient-days, P = .02) but had a similar crude incidence rate of the negative control outcome (4.5 vs 3.2 per 1000 patient-days; P = .10). In multivariable analyses, CHG bathing was associated with a 60% decrease in the primary outcome (adjusted hazard ratio [HR], 0.4; P < .001). In contrast, CHG bathing had no effect on the negative control outcome (adjusted HR, 1.1; P = .781). CHG bathing was well tolerated by participants in the CHG group. CONCLUSIONS: CHG bathing could be a highly effective approach for preventing gram-positive cocci-related, skin flora-related, or central line-associated bacteremia in patients with hematological malignancies who are hospitalized for cytotoxic chemotherapy in noncritical care units.
引用
- Tien KL, Sheng WH, Shieh SC, et al. Chlorhexidine Bathing to Prevent Central Line-Associated Bloodstream Infections in Hematology Units: A Prospective, Controlled Cohort Study. Clin Infect Dis. 2020. PMID: 31504341. doi:10.1093/cid/ciz874
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。